Preeclampsia as an infectious disease

Expert Review of Obstetrics and Gynecology

Volumn 2, Issue 6, 2007, Pages 735-741

  Todros, Tullia ^a   Vasario, Elena ^a   Cardaropoli, Simona ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Doppler ultrasound; endothelial dysfunction; infection; inflammation; placenta; preeclampsia; pregnancy; trophoblast invasion

Indexed keywords

EID: 84983034961     PISSN: 17474108     EISSN: 17474116     Source Type: Journal    
DOI: 10.1586/17474108.2.6.735     Document Type: Article

References (68)

1. ACOG Committee on Obstetric Practice. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33. Int. J. Gynaecol. Obstet. 77, 67–75 (2002).
2. Sibai BM. Hypertension. In: Obstetrics. Normal and Problem Pregnancies (5th Edition). Gabbe SG, Niebyl JR, Simpson JL (Eds). Churchill Livingstone, NY, USA, 863–912 (2007).
3. Bernstein IM, Horbar JD, Badger GJ, Ohlsson A, Golan A. Morbidity and mortality among very-low-birth-weight neonates with intrauterine growth restriction. The Vermont Oxford Network. Am. J. Obstet. Gynecol. 182 (1 Pt 1), 198–206 (2000).
4. Walker JJ. Pre-eclampsia. Lancet 356 (9237), 1260–1265 (2000).
5. Villar J, Carroli G, Wojdyla D et al. Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions? Am. J. Obstet. Gynecol. 194 (4), 921–931 (2006).
6. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science 308 (5728), 1592–1594 (2005).
7. Roberts JM, Gammill HS. Preeclampsia: recent insights. Hypertension 46 (6), 1243–1249 (2005).
8. Espinoza J, Romero R, Mee Kim Y et al. Normal and abnormal transformation of the spiral arteries during pregnancy. J. Perinat. Med. 34 (6), 447–458 (2006).
9. Rigano S, Boito S, Pennati G et al. Uterine artery blood flow volume is reduced and inversely correlated to pulsatility index in pregnancies with increased utero–placental impedance. J. Soc. Gynecol. Investig. 14 (Suppl. 1), 164A (2007).
10. Gomez O, Figueras F, Martinez JM et al. Sequential changes in uterine artery blood flow pattern between the first and second trimesters of gestation in relation to pregnancy outcome. Ultrasound Obstet. Gynecol. 28 (6), 802–808 (2006).
11. Ertan AK, Hendrik HJ, Tanriverdi HA, Bechtold M, Schmidt W. Fetomaternal Doppler sonography nomograms. Clin. Exp. Obstet. Gynecol. 30 (4), 211–216 (2003).
12. Maynard SE, Min JY, Merchan J et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J. Clin. Invest. 111 (5), 649–658 (2003).
13. Venkatesha S, Toporsian M, Lam C et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat. Med. 12 (6), 642–649 (2006). Erratum in: Nat. Med. 12 (7), 862 (2006).
14. Redman CW, Sargent IL. Pre-eclampsia, the placenta and the maternal systemic inflammatory response – a review. Placenta 24 (Suppl. A), S21 –S27 (2003).
15. Widmer M, Villar J, Benigni A, Conde-Agudelo A, Karumanchi SA, Lindheimer M. Mapping the theories of preeclampsia and the role of angiogenic factors: a systematic review. Obstet. Gynecol. 109 (1), 168–180 (2007).
16. Pijnenborg R, Vercruysse L, Hanssens M. The uterine spiral arteries in human pregnancy: facts and controversies. Placenta 27 (9–10), 939–958 (2006).
17. Barden A. Pre-eclampsia: contribution of maternal constitutional factors and the consequences for cardiovascular health. Clin. Exp. Pharmacol. Physiol. 33 (9), 826–830 (2006).
18. Papageorghiou AT, Yu CK, Nicolaides KH. The role of uterine artery Doppler in predicting adverse pregnancy outcome. Best Pract. Res. Clin. Obstet. Gynaecol. 18 (3), 383–396 (2004).
19. Todros T, Ferrazzi E, Arduini D et al. Performance of Doppler ultrasonography as a screening test in low risk pregnancies. Results of a multicentric study. J. Ultrasound Med. 14, 343–348 (1995).
20. von Dadelszen P, Magee LA, Marshall JC, Rotstein OD. The maternal syndrome of preeclampsia: a forme fruste of the systemic inflammatory response syndrome. Sepsis 4 (1), 43–47 (2000).
21. Teran E, Escudero C, Moya W, Flores M, Vallance P, Lopez-Jaramillo P. Elevated C-reactive protein and pro-inflammatory cytokines in Andean women with pre-eclampsia. Int. J. Gynaecol. Obstet. 75 (3), 243–249 (2001).
22. Todros T, Pescarmona GP, Cau MA. Preeclampsia: a state of iron deficiency? J. Soc. Gynecol. Investig. 7 (1), 150A (2000).
23. Serin IS, Ozcelik B, Basbug M, Kilic H, Okur D, Erez R. Predictive value of tumor necrosis factor α (TNF-α) in preeclampsia. Eur. J. Obstet. Gynecol. Reprod. Biol. 100 (2), 143–145 (2002).
24. Todros T, Bontempo S, Piccoli E et al. Increased levels of macrophage migration inhibitory factor (MIF) in preeclampsia. Eur. J. Obstet. Gynecol. Reprod. Biol. 123 (2), 162–166 (2005).
25. Holthe MR, Staff AC, Berge LN, Fagerhol MK, Lyberg T. Calprotectin plasma level is elevated in preeclampsia. Acta Obstet. Gynecol. Scand. 84 (2), 151–154 (2005).
26. Kaleli I, Kaleli B, Demir M, Yildirim B, Cevahir N, Demir S. Serum levels of neopterin and interleukin-2 receptor in women with severe preeclampsia. J. Clin. Lab. Anal. 19 (2), 36–39 (2005).
27. Rayman MP, Barlis J, Evans RW, Redman CW, King LJ. Abnormal iron parameters in the pregnancy syndrome preeclampsia. Am. J. Obstet. Gynecol. 187, 412–418 (2002).
28. Osmanagaoglu MA, Topcuoglu K, Ozeren M, Bozkaya H. Coagulation inhibitors in preeclamptic pregnant women. Arch. Gynecol. Obstet. 271 (3), 227–230 (2005).
29. von Dadelszen P, Magee LA. Could an infectious trigger explain the differential maternal response to the shared placental pathology of preeclampsia and normotensive intrauterine growth restriction? Acta Obstet. Gynecol. Scand. 81 (7), 642–648 (2002).
30. Herrera JA, Chaudhuri G, Lopez-Jaramillo P. Is infection a major risk factor for preeclampsia? Med. Hypotheses 57 (3), 393–397 (2001).
31. Lopez-Jaramillo P, Casas JP, Serrano N. Preeclampsia: from epidemiological observations to molecular mechanisms. Braz. J. Med. Biol. Res. 34 (10), 1227–1235 (2001).
32. Banhidy F, Acs N, Puho EH, Czeizel AE. Maternal urinary tract infection and related drug treatments during pregnancy and risk of congenital abnormalities in the offspring. Br. J. Obstet. Gynaecol. 113 (12), 1465–1471 (2006).
33. Kunnen A, Blaauw J, van Doormaal JJ et al. Women with a recent history of early-onset pre-eclampsia have a worse periodontal condition. J. Clin. Periodontol. 34 (3), 202–207 (2007).
34. Contreras A, Herrera JA, Soto JE, Arce RM, Jaramillo A, Botero JE. Periodontitis is associated with preeclampsia in pregnant women. J. Periodontol. 77 (2), 182–188 (2006).
35. Cota LO, Guimaraes AN, Costa JE, Lorentz TC, Costa FO. Association between maternal periodontitis and an increased risk of preeclampsia. J. Periodontol. 77 (12), 2063–2069 (2006).
36. Oettinger-Barak O, Barak S, Ohel G et al. Severe pregnancy complication (preeclampsia) is associated with greater periodontal destruction. J. Periodontol. 76 (1), 134–137 (2005).
37. Canakci V, Canakci CF, Canakci H et al. Periodontal disease as a risk factor for pre-eclampsia: a case control study. Aust. NZ J. Obstet. Gynaecol. 44 (6), 568–573 (2004).
38. Boggess KA, Lieff S, Murtha AP, Moss K, Beck J, Offenbacher S. Maternal periodontal disease is associated with an increased risk for preeclampsia. Obstet. Gynecol. 101 (2), 227–231 (2003).
39. Khader YS, Jibreal M, Al-Omiri M, Amarin Z. Lack of association between periodontal parameters and preeclampsia. J. Periodontol. 77 (10), 1681–1687 (2006).
40. Boggess KA, Edelstein BL. Oral health in women during preconception and pregnancy: implications for birth outcomes and infant oral health. Matern. Child Health J. 10 (5 Suppl.), S169 –S174 (2006).
41. Shub A, Swain JR, Newnham JP. Periodontal disease and adverse pregnancy outcomes. J. Matern. Fetal Neonatal Med. 19 (9), 521–528 (2006).
42. Xiong X, Buekens P, Fraser WD, Beck J, Offenbacher S. Periodontal disease and adverse pregnancy outcomes: a systematic review. Br. J. Obstet. Gynaecol. 113 (2), 135–143 (2006).
43. Barak S, Oettinger-Barak O, Machtei EE, Sprecher H, Ohel G. Evidence of periopathogenic microorganisms in placentas of women with preeclampsia. J. Periodontol. 78 (4), 670–676 (2007).
44. Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. Br. Med. J. 330 (7491), 565–571 (2005).
45. Shoenfeld Y, Blank M, Cervera R, Font J, Raschi E, Meroni PL. Infectious origin of the antiphospholipid syndrome. Ann. Rheum. Dis. 65 (1), 2–6 (2006).
46. Arechavaleta-Velasco F, Ma Y, Zhang J, McGrath CM, Parry S. Adeno-associated virus-2 (AAV-2) causes trophoblast dysfunction, and placental AAV-2 infection is associated with preeclampsia. Am. J. Pathol. 168 (6), 1951–1959 (2006).
47. Trogstad LI, Eskild A, Bruu AL, Jeansson S, Jenum PA. Is preeclampsia an infectious disease? Acta Obstet. Gynecol. Scand. 80 (11), 1036–1038 (2001).
48. Arechavaleta-Velasco F, Koi H, Strauss JF 3rd, Parry S. Viral infection of the trophoblast: time to take a serious look at its role in abnormal implantation and placentation? J. Reprod. Immunol. 55 (1–2), 113–121 (2002).
49. Brabin BJ, Johnson PM. Placental malaria and pre-eclampsia through the looking glass backwards? J. Reprod. Immunol. 65 (1), 1–15 (2005).
50. Anya SE. Seasonal variation in the risk and causes of maternal death in the Gambia: malaria appears to be an important factor. Am. J. Trop. Med. Hyg. 70 (5), 510–513 (2004).
51. Sartelet H, Rogier C, Milko-Sartelet I, Angel G, Michel G. Malaria associated preeclampsia in Senegal. Lancet 347 (9008), 1121 (1996).
52. Lindsberg PJ, Grau AJ. Inflammation and infections as risk factors for ischemic stroke. Stroke 34 (10), 2518–2532 (2003).
53. Ponzetto A, Cardaropoli S, Piccoli E et al. Pre-eclampsia is associated with Helicobacter pylori seropositivity in Italy. J. Hypertens. 24 (12), 2445–2449 (2006).
54. Heine RP, Ness RB, Roberts JM. Seroprevalence of antibodies to Chlamydia pneumoniae in women with preeclampsia. Obstet. Gynecol. 101 (2), 221–226 (2003).
55. Aral M, Guven MA, Kocturk SA. Chlamydia pneumoniae seropositivity in women with pre-eclampsia. Int. J. Gynaecol. Obstet. 92 (1), 77–78 (2006).
56. Goulis DG, Chappell L, Gibbs RG et al. Association of raised titres of antibodies to Chlamydia pneumoniae with a history of pre-eclampsia. Br. J. Obstet. Gynaecol. 112 (3), 299–305 (2005).
57. Raynor BD, Bonney EA, Jang KT, Coto W, Garcia MS. Preeclampsia and Chlamydia pneumoniae: is there a link? Hypertens. Pregnancy. 23 (2), 129–134 (2004).
58. Teran E, Escudero C, Calle A. Seroprevalence of antibodies to Chlamydia pneumoniae in women with preeclampsia. Obstet. Gynecol. 102 (1), 198–199 (2003).
59. von Dadelszen P, Magee LA, Krajden M et al. Levels of antibodies against cytomegalovirus and Chlamydophila pneumoniae are increased in early onset preeclampsia. Br. J. Obstet. Gynaecol. 110 (8), 725–730 (2003).
60. Rustveld LO, Kelsey SF, Sharma R. Association between maternal infections and preeclampsia: a systematic review of epidemiologic studies. Matern. Child. Health J. (2007) [Epub ahead of print].
61. Hippenstiel S, Suttorp N. Interaction of pathogens with the endothelium. Thromb. Haemost. 89 (1), 18–24 (2003).
62. Franceschi F, Sepulveda AR, Gasbarrini A et al. Cross-reactivity of anti-CagA antibodies with vascular wall antigens: possible pathogenic link between Helicobacter pylori infection and atherosclerosis. Circulation 106 (4), 430–434 (2002).
63. Faas MM, Schuiling GA, Baller JF, Visscher CA, Bakker WW. A new animal model for human preeclampsia: ultra-low-dose endotoxin infusion in pregnant rats. Am. J. Obstet. Gynecol. 171 (1), 158–164 (1994).
64. Cardaropoli S, Silvagno F, Morra E, Pescarmona GP, Todros T. Infectious and inflammatory stimuli decrease endothelial nitric oxide synthase activity in vitro. J. Hypertens. 21 (11), 2103–2110 (2003).
65. Panarelli M, Sattar N. Pre-eclampsia associated with Helicobacter pylori seropositivity. J. Hypertens. 24 (12), 2353–2354 (2006).
66. Todros T, Verdiglione P, Ogge G, Paladini D, Vergani P, Cardaropoli S. Low incidence of hypertensive disorders of pregnancy in women treated with spiramycin for toxoplasma infection. Br. J. Clin. Pharmacol. 61 (3), 336–340 (2006).
67. Vainio M, Kujansuu E, Koivisto AM, Maenpaa J. Bilateral notching of uterine arteries at 12–14 weeks of gestation for prediction of hypertensive disorders of pregnancy. Acta Obstet. Gynecol. Scand. 84 (11), 1062–1067 (2005).
68. Mathew D, Thornton JG, Todros T, Khan K. Antibiotics for preventing hypertensive diseases in pregnancy. (Protocol) Cochrane Database Syst. Rev. (2007) (In press).